Stem cells and AI team up to predict cardiac arrhythmias in patients - EurekAlert

New research lays the foundation for machine learning-based patient risk profiling and drug toxicity testing in patient-derived cardiomyocytes, which could help to generate safer and more effective medicines.

image: Screening cultured stem cell-derived cardiomyocytes for arrhythmias using machine learning.view more  Credit: Designed by researchers from the Institute of Molecular and Cell Biology, Singapo… [+1966 chars]

full article...